Harvard Bioscience (HBIO) Current Leases (2019 - 2025)
Harvard Bioscience (HBIO) has disclosed Current Leases for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.
- Quarterly Current Leases rose 31.69% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 31.69% year-over-year, with the annual reading at $1.5 million for FY2025, 31.69% up from the prior year.
- Current Leases for Q4 2025 was $1.5 million at Harvard Bioscience, up from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $2.2 million in Q1 2022, with the low at $1.1 million in Q2 2024.
- Average Current Leases over 5 years is $1.8 million, with a median of $2.1 million recorded in 2021.
- The sharpest move saw Current Leases crashed 50.21% in 2024, then soared 37.33% in 2025.
- Over 5 years, Current Leases stood at $2.1 million in 2021, then dropped by 0.33% to $2.1 million in 2022, then plummeted by 33.68% to $1.4 million in 2023, then dropped by 18.22% to $1.2 million in 2024, then skyrocketed by 31.69% to $1.5 million in 2025.
- According to Business Quant data, Current Leases over the past three periods came in at $1.5 million, $1.5 million, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.